RespireRx Financial Statements From 2010 to 2026
| RSPI Stock | USD 0 0.00 0.00% |
Check RespireRx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RespireRx Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . RespireRx financial statements analysis is a perfect complement when working with RespireRx Pharmaceuticals Valuation or Volatility modules.
RespireRx |
RespireRx Pharmaceuticals Company Return On Asset Analysis
RespireRx Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current RespireRx Pharmaceuticals Return On Asset | -8.34 |
Most of RespireRx Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RespireRx Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, RespireRx Pharmaceuticals has a Return On Asset of -8.3401. This is 4.68% lower than that of the Pharmaceuticals sector and 64.66% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
RespireRx Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RespireRx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare RespireRx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RespireRx Pharmaceuticals competition to find correlations between indicators driving RespireRx Pharmaceuticals's intrinsic value. More Info.RespireRx Pharmaceuticals is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value RespireRx Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for RespireRx Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About RespireRx Pharmaceuticals Financial Statements
Investors use fundamental indicators, such as RespireRx Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although RespireRx Pharmaceuticals' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. RespireRx Pharmaceuticals Inc. was incorporated in 1987 and is headquartered in Glen Rock, New Jersey. Respirerx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Currently Active Assets on Macroaxis
Other Information on Investing in RespireRx Pink Sheet
RespireRx Pharmaceuticals financial ratios help investors to determine whether RespireRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RespireRx with respect to the benefits of owning RespireRx Pharmaceuticals security.